Siemens Healthineers to Invest EUR 350 Million in New Campus Forchheim

Siemens HealthineersSiemens Healthineers is planning to expand its location in Forchheim in response to the continuing strong demand for medical imaging devices, in particular for CT scanners and x-ray applications. The new "Siemens Healthineers Campus" will consist of an ultra-modern factory for medical components and a new R&D and logistics center alongside the existing facilities. Siemens Healthineers will be investing around EUR 350 million in this project over the next five years. Construction at the site is scheduled to begin in 2020.

"With its IPO, Siemens Healthineers set itself the clear ambition to shape the future of healthcare. This forward-looking investment into the Forchheim campus is a critical milestone paying into this direction. It reinforces our claim to generate sustainable, profitable growth based on the strength of our market and technology leadership as well as demonstrating our commitment to our home market Germany," said Michael Sen, Supervisory Board Chairman of Siemens Healthineers.

"This is one of the biggest investments ever made by Siemens Healthineers. Construction of this ultra-modern campus in Forchheim demonstrates our commitment to meeting the strong demand for imaging technology and will help us secure our position as an innovation and market leader," stated Bernd Montag, CEO of Siemens Healthineers.

Production of x-ray tube assemblies and generators for x-ray machines is planned to begin in 2023. The new facilities will consist of 47,000 square meters, and the existing production for these components in Erlangen, with around 700 employees, will be relocated to Forchheim. The new state-of-the-art facility will make production less costly, enhance the quality of the products and provide adequate capacities for further growth.

The company currently has separate facilities for x-ray machines and generators in the neighboring city of Erlangen. Expansion of the production capacities at the existing locations is not possible due to a lack of space. Siemens Healthineers is therefore also expanding its Forchheim location by purchasing more land. The Forchheim city council already approved the preliminary planning application in October 2018. Buildings being vacated in Erlangen will be used for other purposes by Siemens Healthineers and Siemens AG in the future.

In addition to the production and administration buildings at the site, Siemens Healthineers plans to construct a test and development center at the Forchheim Campus. Construction of a car park for employees on the site is also planned. The pace of innovation and development and exploitation of synergy potential are to be accelerated and enhanced through the close interaction of the two production facilities and direct proximity to the business units. For example, CT scanners are to be built in Forchheim, thus shortening the supply channels for the x-ray tube assemblies and generators used in these products to a minimum in the future. Having the business units in the immediate vicinity will also improve coordination in the development and production of the equipment.

The headquarters of both the Diagnostic Imaging (DI) and Advanced Therapy (AT) business segments are currently located in Forchheim. The future Campus will consist of the existing production and administration buildings, along with the new development and production facilities for x-ray tube assemblies and generators.

X-ray tube assemblies and x-ray generators are medical components used in CT scanners, for example. The x-ray tube assemblies contain the x-ray tubes that generate the x-ray radiation. X-ray generators include all the components required for operation of the x-ray tubes. They also generate and regulate the high voltage required for operation of the x-ray tubes.

About Siemens Healthineers

Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services.

In fiscal 2018, which ended on September 30, 2018, Siemens Healthineers generated revenue of €13.4 billion and adjusted profit of €2.3 billion and has about 50,000 employees worldwide.

Most Popular Now

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Groundbreaking TACIT Algorithm Offers Ne…

Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary tool for determining the best options for patients - both in the treatment...

The Many Ways that AI Enters Rheumatolog…

High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in systemic sclerosis (SSc). But AI-assisted interpretation has the potential...